SCHEMBL5136341

SCHEMBL5136341

O=C(O)c1c(S(=O)(=O)Cl)c2ccccc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.47
ACLY P53396 1/20 0.46
AGTR1 P30556 4/20 0.45
FABP3 P05413 2/20 0.44
FABP4 P15090 2/20 0.44
FABP5 Q01469 2/20 0.44
SRC P12931 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FABP2 P12104 1/20 0.41
PSEN1 P49768 2/20 0.40
PSEN2 P49810 2/20 0.40
APH1B Q8WW43 2/20 0.40
NCSTN Q92542 2/20 0.40
APH1A Q96BI3 2/20 0.40
PSENEN Q9NZ42 2/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C1 Q04828 1/20 0.40
PLK1 P53350 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823347 0.85 ACLY (0.62) HTR6ACLYSRCLMNAPSEN1
SCHEMBL12392496 0.82 NOD2 (0.48) HTR6AGTR1LMNAPSEN1PSEN2
SCHEMBL4119321 0.82 ACLY (0.51) HTR6ACLYAGTR1FABP3FABP4
SCHEMBL2732076 0.79 FABP3 (0.50) HTR6ACLYAGTR1FABP3FABP4
SCHEMBL6829775 0.79 AKR1C3 (0.48) HTR6ACLYAGTR1FABP3FABP4
SCHEMBL28019783 0.79 AGTR1 (0.47) HTR6ACLYAGTR1FABP3FABP4
SCHEMBL28184674 0.74 AGTR1 (0.60) HTR6ACLYAGTR1SMN1; SMN2PSEN1
SCHEMBL12093313 0.74 HTR6 (0.70) HTR6FABP3FABP4FABP5SRC
SCHEMBL2929010 0.72 MEN1 (0.45) HTR6SRCPSEN1PSEN2APH1B
SCHEMBL20505521 0.71 AGTR1 (0.60) HTR6AGTR1SMN1; SMN2PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898927-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Merck & Co., Inc. (US) 2008-03-19 EP disclosed
WO-2007002481-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MERCK & CO., INC. (US) 2007-01-04 WO disclosed